Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Kristen E. Nailor is active.

Publication


Featured researches published by Kristen E. Nailor.


Bioorganic & Medicinal Chemistry Letters | 2009

Design of potent thiophene inhibitors of polo-like kinase 1 with improved solubility and reduced protein binding.

Kyle Allen Emmitte; George M. Adjebang; C. Webb Andrews; Jennifer G. Badiang Alberti; Ramesh Bambal; Stanley D. Chamberlain; Ronda G. Davis-Ward; Hamilton D. Dickson; Daniel F. Hassler; Keith R. Hornberger; Jeffrey R. Jackson; Kevin Wayne Kuntz; Timothy J. Lansing; Robert A. Mook; Kristen E. Nailor; Mark Andrew Pobanz; Stephon C. Smith; Chiu-Mei Sung; Mui Cheung

A series of thiophene PLK1 inhibitors was optimized for increased solubility and reduced protein binding through the appendage of basic amine functionality. Interesting selectivity between PLK1 and PLK3 was also obtained through these modifications.


Bioorganic & Medicinal Chemistry Letters | 2009

Discovery of thiophene inhibitors of polo-like kinase.

Kyle Allen Emmitte; C. Webb Andrews; Jennifer Gabriel Badiang; Ronda G. Davis-Ward; Hamilton D. Dickson; David H. Drewry; Holly Kathleen Emerson; Andrea H. Epperly; Daniel F. Hassler; Victoria B. Knick; Kevin Wayne Kuntz; Timothy J. Lansing; James A. Linn; Robert A. Mook; Kristen E. Nailor; James Michael Salovich; Glenn M. Spehar; Mui Cheung

The discovery and development of a series of thiophenes as potent and selective inhibitors of PLK is described. Identification and characterization of 2, a useful in vitro PLK inhibitor tool compound, is also presented.


Bioorganic & Medicinal Chemistry Letters | 2009

Discovery and optimization of imidazo[1,2-a]pyridine inhibitors of insulin-like growth factor-1 receptor (IGF-1R)

Kyle Allen Emmitte; Brian John Wilson; Erich W. Baum; Holly Kathleen Emerson; Kevin Wayne Kuntz; Kristen E. Nailor; James Michael Salovich; Stephon C. Smith; Mui Cheung; Roseanne M. Gerding; Kirk L. Stevens; David E. Uehling; Robert A. Mook; Ganesh S. Moorthy; Scott Howard Dickerson; Anne M. Hassell; M. Anthony Leesnitzer; Lisa M. Shewchuk; Arthur Groy; Jason L. Rowand; Kelly Anderson; Charity Atkins; Jingsong Yang; Peter Sabbatini; Rakesh Kumar

The optimization of imidazo[1,2-a]pyridine inhibitors as potent and selective inhibitors of IGF-1R is presented. Further optimization of oral exposure in mice is also discussed. Detailed selectivity, in vitro activity, and in vivo PK profiles of an optimized compound is also highlighted.


Archive | 2003

Diamino-pyrimidines and their use as angiogenesis inhibitors

Stanley D. Chamberlain; Mui Cheung; Holly Kathleen Emerson; Neil W. Johnson; Kristen E. Nailor; Douglas Mccord Sammond; Marcus Semones


Bioorganic & Medicinal Chemistry Letters | 2005

Discovery of a novel and potent series of dianilinopyrimidineurea and urea isostere inhibitors of VEGFR2 tyrosine kinase

Douglas Mccord Sammond; Kristen E. Nailor; James M. Veal; Robert T. Nolte; Liping Wang; Victoria B. Knick; Sharon K. Rudolph; Anne T. Truesdale; Eldridge N. Nartey; Jeffrey A. Stafford; Rakesh Kumar; Mui Cheung


Archive | 2008

Imidazopyridine Kinase Inhibitors

Kevin Kuntz; David E. Uehling; Alex G. Waterson; Kyle Allen Emmitte; Kirk L. Stevens; John Brad Shotwell; Stephon C. Smith; Kristen E. Nailor; James Michael Salovich; Brian John Wilson; Mui Cheung; Robert A. Mook; Erich W. Baum; Ganesh S. Moorthy


Cancer Research | 2007

Identification of GSK461364, a novel small molecule polo-like kinase 1 inhibitor for the treatment of cancer

Kevin Wayne Kuntz; James Michael Salovich; Robert A. Mook; Kyle Allen Emmitte; Stanley D. Chamberlain; Tara Renae Rheault; Keith R. Hornberger; Holly Kathleen Emerson; Stephon C. Smith; Brian John Wilson; Ronda G. Davis-Ward; Kelly Horne Donaldson; George M. Adjabeng; Kristen E. Nailor; Daniel F. Hassler; Gary K. Smith; Timothy J. Lansing; Derek Duckett; Victoria B. Knick; Randy T. McConnell; Jeffrey Jackson; Mui Cheung


Bioorganic & Medicinal Chemistry Letters | 2009

Corrigendum to “Design of potent thiophene inhibitors of polo-like kinase 1 with improved solubility and reduced protein binding” [Bioorg. Med. Chem. Lett. 19 (2009) 1694]

Kyle Allen Emmitte; George M. Adjabeng; C. Webb Andrews; Jennifer G. Badiang Alberti; Ramesh Bambal; Stanley D. Chamberlain; Ronda G. Davis-Ward; Hamilton D. Dickson; Daniel F. Hassler; Keith R. Hornberger; Jeffrey R. Jackson; Kevin Wayne Kuntz; Timothy J. Lansing; Robert A. Mook; Kristen E. Nailor; Mark Andrew Pobanz; Stephon C. Smith; Chiu-Mei Sung; Mui Cheung


publisher | None

title

author


Archive | 2007

DIAMINOPYRIMIDINE UND DEREN VERWENDUNG ALS ANGIOGENESEHEMMER

Stanley D. Chamberlain; Mui Cheung; Holly Kathleen Emerson; Neil W. Johnson; Kristen E. Nailor; Douglas Mccord Sammond; Marcus Semones

Collaboration


Dive into the Kristen E. Nailor's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge